Stock ACLX ARCELLX, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Press Releases Arcellx, Inc.

Equities

ACLX

US03940C1009

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-24 pm EDT 		5-day change 1st Jan Change
51.9 USD +2.51% Intraday chart for Arcellx, Inc. -3.21% -6.49%
May. 15 Stifel Adjusts Price Target on Arcellx to $83 From $82, Maintains Buy Rating MT
May. 14 Evercore ISI Starts Arcellx With Outperform Rating MT

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Arcellx : IMMagine-3 Multi-center, Global, Phase 3 Randomized Control Clinical Trial Design
PU
Arcellx and Kite Continue Momentum with Advances in Anito-Cel Multiple Myeloma Program
BU
Arcellx Provides First Quarter 2024 Financial Results
BU
Arcellx to Participate in Two Upcoming Investor Conferences
BU
Arcellx to Participate in the 23rd Annual Needham Virtual Healthcare Conference
BU
Arcellx to Participate at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
BU
Arcellx to Participate at the TD Cowen 44th Annual Health Care Conference
PR
Arcellx Provides Fourth Quarter and Year-End 2023 Financial Results and Business Highlights
PR
Arcellx Announces Continued Robust Long-Term Responses from Its CART-ddBCMA Phase 1 Expansion Trial in Patients with Relapsed or Refractory Multiple Myeloma at ASH
AQ
Arcellx Announces Oral Presentation for Its CART-ddBCMA Phase 1 Trial in Patients with Relapsed or Refractory Multiple Myeloma at the 65th ASH Annual Meeting and Exposition
AQ
Arcellx : November 2023 Corporate Presentation
PU
Arcellx to Participate in Two Upcoming Investor Conferences
PR
Arcellx : September 2023 Corporate Presentation
PU
Arcellx : August 2023 Corporate Presentation
PU
Arcellx Announces Partial Clinical Hold Lifted on iMMagine-1 Phase 2 Clinical Program and Reports Second Quarter Financial Results
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX
PR
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX
PR
Arcellx : Corporate Presentation July 2023
PU
Pomerantz Law Firm Investigates Claims On Behalf of Investors of Arcellx, Inc. - ACLX
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. ACLX Stock
  4. News Arcellx, Inc.
  5. Press Releases